SteadySharesSteadyShares
Try now

Tybourne Capital

Tybourne Capital Management · SEC CIK 1553936

Asia-informed global long/short.

Q3 2025
Latest 13F
$30.93M
Filed US book
4
Positions

Largest holdings, as filed

Top 4 of 4 positions. Weights are against the whole filed book. 13F filings cover US-listed holdings only.

CompanyTickerValueWeight
TAYSHA GENE THERAPIES INC (TSHA US)TSHA$12.10M39.1%
FORTE BIOSCIENCES INC (FBRX US)FBRX$11.80M38.1%
ALUMIS INC (ALMS US)ALMS$5.58M18.1%
ZENTALIS PHARMACEUTICALS INC (ZNTL US)ZNTL$1.45M4.7%

Inside the app: the full book for Tybourne Capital Management, quarter on quarter buys and sells, consensus across 100+ funds and copy-to-watchlist.

Create a free accountAll tracked investors

Source: SEC EDGAR 13F filings. Values are as filed and cover US-listed positions only. Educational information, not financial advice.